|
ADAM10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.00079997014768E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.133399999524E-07 |
| Normal-vs-Stage2 |
1.62069999999348E-05 |
| Normal-vs-Stage3 |
2.32010000100757E-08 |
| Normal-vs-Stage4 |
1.12739999558187E-08 |
| Stage1-vs-Stage2 |
3.572600E-01 |
| Stage1-vs-Stage3 |
1.495420E-01 |
| Stage1-vs-Stage4 |
1.294230E-02 |
| Stage2-vs-Stage3 |
8.992400E-01 |
| Stage2-vs-Stage4 |
3.476800E-01 |
| Stage3-vs-Stage4 |
3.479400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63679999554134E-08 |
| Normal-vs-AfricanAmerican |
1.235790E-02 |
| Normal-vs-Asian |
2.42240000003502E-06 |
| Caucasian-vs-AfricanAmerican |
3.162000E-01 |
| Caucasian-vs-Asian |
4.752400E-01 |
| AfricanAmerican-vs-Asian |
1.603000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.68239999709385E-08 |
| Normal-vs-Female |
1.77629999598139E-08 |
| Male-vs-Female |
4.442800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.93710000001768E-06 |
| Normal-vs-Age(41-60Yrs) |
9.77740000074334E-09 |
| Normal-vs-Age(61-80Yrs) |
1.56239999826724E-08 |
| Normal-vs-Age(81-100Yrs) |
1.334300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.293400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.421700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.930600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.636200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.572000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.259000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.020990E-01 |
| Classical-VS-Follicular |
3.684800E-03 |
| Classical-VS-Other |
6.309800E-01 |
| Classical-VS-Normal |
6.57339999987627E-07 |
| Tall-VS-Follicular |
8.006600E-01 |
| Tall-VS-Other |
7.148800E-01 |
| Tall-VS-Normal |
1.02589999995129E-06 |
| Follicular-VS-Other |
6.421400E-01 |
| Follicular-VS-Normal |
5.69489999602268E-09 |
| Other-VS-Normal |
3.545600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.01320000167604E-08 |
| Normal-vs-N1 |
2.00000000005751E-07 |
| N0-vs-N1 |
3.110400E-01 |
|
|
